Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer.

Saved in:
Bibliographic Details
Title: Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer.
Authors: Ahangar M; Department of Clinical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran., Mischak H; Department of Biomarker Research, Mosaiques Diagnostics GmbH, Hannover, Germany., Moulavasilis N; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Stravodimos K; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Mahjoubi F; Department of Clinical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran., Jankowski J; Institute For Molecular Cardiovascular Research, RWTH Aachen University Hospital, Aachen, Germany., Frantzi M; Department of Biomarker Research, Mosaiques Diagnostics GmbH, Hannover, Germany., Vlahou A; Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Source: Proteomics [Proteomics] 2026 Jul; Vol. 26 (7), pp. 169-180. Date of Electronic Publication: 2026 Apr 27.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101092707 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-9861 (Electronic) Linking ISSN: 16159853 NLM ISO Abbreviation: Proteomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1615-9861
DOI:10.1002/pmic.70135